On July 25, 2023, the Ministry of Health, Labour and Welfare (MHLW) of Japan issued an announcement, stating thatΔ8-THCH and Δ9-THCH would be classified as designated drugs. Therefore the manufacturing, import, sale, possession, and non-medical use of these designated drugs will be strictly prohibited. This announcement came into effect on August 4, 2023.